152 AttackMS natalizumab for the treatment of people with inflammatory demyeli- nation suggestive of multiple sclerosis

K Schmierer, I Redha, V Hammond, D Baker, F Barkhof, R Hooper, W Rashid, V Singh-Curry, J Hobart, G Giovannoni

Research output: Contribution to conferenceConference paper (not formally published)peer-review

Original languageEnglish
DOIs
Publication statusPublished - Sept 2022

Cite this